Efficacy and Safety of BIA 9-1067 in Idiopathic Parkinson's Disease Patients With "Wearing-off" Phenomenon

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2011
This study aims to demonstrate the efficacy and safety of BIA 9-1067, compared with entacapone or placebo, when administered with the existing treatment of L-DOPA plus a Dopa Decarboxylase Inhibitor (DDCI), in patients with Parkinson\'s Disease (PD) and end-of-dose motor fluctuations.
Epistemonikos ID: 30da02c90246e5f47cc1ff232b45139a71e48afe
First added on: May 10, 2024